Luca Visconti

751 total citations
26 papers, 435 citations indexed

About

Luca Visconti is a scholar working on Nephrology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Luca Visconti has authored 26 papers receiving a total of 435 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Nephrology, 5 papers in Molecular Biology and 5 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Luca Visconti's work include Trace Elements in Health (3 papers), Apelin-related biomedical research (3 papers) and Iron Metabolism and Disorders (3 papers). Luca Visconti is often cited by papers focused on Trace Elements in Health (3 papers), Apelin-related biomedical research (3 papers) and Iron Metabolism and Disorders (3 papers). Luca Visconti collaborates with scholars based in Italy, France and United States. Luca Visconti's co-authors include Domenico Santoro, Michele Buemi, Valeria Cernaro, Antonio Lacquaniti, Guido Gembillo, Carlo Alberto Ricciardi, Rossella Siligato, Giovanni Conti, Antoine Buemi and Giuseppe Coppolino and has published in prestigious journals such as SHILAP Revista de lepidopterología, Nutrients and Medicine.

In The Last Decade

Luca Visconti

24 papers receiving 423 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Luca Visconti Italy 13 175 91 64 61 59 26 435
Edyta Gołembiewska Poland 11 189 1.1× 74 0.8× 36 0.6× 49 0.8× 81 1.4× 55 488
Rossella Siligato Italy 12 169 1.0× 49 0.5× 42 0.7× 91 1.5× 49 0.8× 31 433
Claudia Fofi Italy 9 209 1.2× 60 0.7× 33 0.5× 46 0.8× 61 1.0× 21 447
Jorge Rojas-Rivera Spain 14 408 2.3× 119 1.3× 65 1.0× 70 1.1× 57 1.0× 29 602
Kazushi Nakao Japan 14 236 1.3× 48 0.5× 39 0.6× 87 1.4× 103 1.7× 24 465
Der-Cherng Tarng Taiwan 13 179 1.0× 68 0.7× 28 0.4× 48 0.8× 77 1.3× 17 469
Torbjörn Linde Sweden 11 275 1.6× 90 1.0× 54 0.8× 46 0.8× 106 1.8× 24 629
Hiroyuki Kadoya Japan 15 213 1.2× 57 0.6× 46 0.7× 101 1.7× 95 1.6× 34 550
Nelson Kopyt United States 12 408 2.3× 132 1.5× 70 1.1× 63 1.0× 122 2.1× 24 622
Michela Mangano Italy 6 341 1.9× 104 1.1× 94 1.5× 45 0.7× 122 2.1× 11 585

Countries citing papers authored by Luca Visconti

Since Specialization
Citations

This map shows the geographic impact of Luca Visconti's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Luca Visconti with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Luca Visconti more than expected).

Fields of papers citing papers by Luca Visconti

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Luca Visconti. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Luca Visconti. The network helps show where Luca Visconti may publish in the future.

Co-authorship network of co-authors of Luca Visconti

This figure shows the co-authorship network connecting the top 25 collaborators of Luca Visconti. A scholar is included among the top collaborators of Luca Visconti based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Luca Visconti. Luca Visconti is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gembillo, Guido, Luca Soraci, & Luca Visconti. (2025). Unveiling the gut-kidney dialogue in diabetic kidney disease. World Journal of Diabetes. 16(11). 112440–112440.
2.
Visconti, Luca, et al.. (2024). Inferior vena cava filters: Concept review and summary of current guidelines. Vascular Pharmacology. 155. 107375–107375. 4 indexed citations
3.
Gembillo, Guido, et al.. (2024). Copper Serum Levels in the Hemodialysis Patient Population. Medicina. 60(9). 1484–1484. 1 indexed citations
4.
Gembillo, Guido, et al.. (2023). Lung Dysfunction and Chronic Kidney Disease: A Complex Network of Multiple Interactions. Journal of Personalized Medicine. 13(2). 286–286. 14 indexed citations
5.
Rossi, Luca, Samer Angelone, Serena Robetto, et al.. (2022). Unintentional Recovery of Parasitic Diversity Following Restoration of Red Deer (Cervus elaphus) in North-Western Italy. Animals. 12(11). 1433–1433.
6.
Gembillo, Guido, Luca Visconti, Alfio Edoardo Giuffrida, et al.. (2022). Role of Zinc in Diabetic Kidney Disease. Nutrients. 14(7). 1353–1353. 33 indexed citations
7.
Gembillo, Guido, Luca Visconti, Rossella Siligato, et al.. (2021). Cardiorenal Syndrome: New Pathways and Novel Biomarkers. Biomolecules. 11(11). 1581–1581. 41 indexed citations
8.
Visconti, Luca, Antonio Lacquaniti, Francesca Gregorio, et al.. (2017). The Myth of Water and Salt: From Aquaretics to Tenapanor. Journal of Renal Nutrition. 28(2). 73–82. 7 indexed citations
9.
Santoro, Domenico, Luca Visconti, Carlo Alberto Ricciardi, et al.. (2016). New options for the management of polycystic kidney disease. 28(2). 143–152. 1 indexed citations
10.
Visconti, Luca, Salvatore Benvenga, Antonio Lacquaniti, et al.. (2016). Lipid disorders in patients with renal failure: Role in cardiovascular events and progression of chronic kidney disease. Journal of Clinical & Translational Endocrinology. 6. 8–14. 42 indexed citations
11.
Visconti, Luca, Domenico Santoro, Valeria Cernaro, Michele Buemi, & Antonio Lacquaniti. (2016). Kidney-lung connections in acute and chronic diseases: current perspectives. Journal of Nephrology. 29(3). 341–348. 28 indexed citations
12.
Visconti, Luca, Valeria Cernaro, Carlo Alberto Ricciardi, et al.. (2016). Renal biopsy: Still a landmark for the nephrologist. World Journal of Nephrology. 5(4). 321–321. 40 indexed citations
13.
Cernaro, Valeria, Domenico Santoro, Antonio Lacquaniti, et al.. (2016). Phosphate binders for the treatment of chronic kidney disease: role of iron oxyhydroxide. International Journal of Nephrology and Renovascular Disease. 9. 11–11. 30 indexed citations
14.
Visconti, Luca, Valeria Cernaro, Giuseppe Costantino, et al.. (2016). Metformin-related lactic acidosis: is it a myth or an underestimated reality?. Renal Failure. 38(9). 1560–1565. 23 indexed citations
15.
Filomia, Roberto, S. Maimone, Gaia Caccamo, et al.. (2016). Acute kidney injury in cirrhotic patients undergoing contrast-enhanced computed tomography. Medicine. 95(38). e4836–e4836. 10 indexed citations
16.
Santoro, Domenico, et al.. (2015). An overview of experimental and early investigational therapies for the treatment of polycystic kidney disease. Expert Opinion on Investigational Drugs. 24(9). 1199–1218. 8 indexed citations
17.
Ricciardi, Carlo Alberto, Antonio Lacquaniti, Valeria Cernaro, et al.. (2015). Salt–water imbalance and fluid overload in hemodialysis patients: a pivotal role of corin. Clinical and Experimental Medicine. 16(3). 443–449. 8 indexed citations
18.
Visconti, Luca, Giuseppe Leonardi, Michele Buemi, et al.. (2015). Kidney disease and psoriasis: novel evidences beyond old concepts. Clinical Rheumatology. 35(2). 297–302. 24 indexed citations
19.
Coppolino, Giuseppe, Valeria Cernaro, Luca Visconti, et al.. (2015). Nephro-oncology: a link in evolution. Renal Failure. 37(8). 1260–1266. 6 indexed citations
20.
Santoro, Domenico, et al.. (2015). Monoclonal antibodies for renal diseases: current concepts and ongoing treatments. Expert Opinion on Biological Therapy. 15(8). 1119–1143. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026